🏛️ Verified NIH Record • Updated 2026-06-02
A Study to Evaluate the Effect of KarXT on Urological Safety (NCT07221877)
A 12-month Open-label, Phase 4 Multicenter Safety Study to Evaluate the Effect of KarXT on Voiding Dynamics and Urological Safety
🟢 Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: Bristol-Myers Squibb
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.
Who can join: Review the eligibility criteria below.
Location: Pillar Clinical Research- Little Rock — Little Rock, Arkansas
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- Pillar Clinical Research- Little Rock — Little Rock, Arkansas
- Clinical Innovations, Inc. dba CITrials — Bellflower, California
- CenExel CNS - Garden Grove — Garden Grove, California
- ATP Clinical Research — Orange, California
- Innovative Clinical Research — Lauderhill, Florida
- Health Synergy Clinical Research — West Palm Beach, Florida
- Uptown Research Institute — Chicago, Illinois
- Pillar Clinical Research -Chicago — Chicago, Illinois
- IMA Clinical Research Las Vegas — Las Vegas, Nevada
- Hassman Research Institute Marlton Site — Marlton, New Jersey
- Adams Clinical Philadelphia — Philadelphia, Pennsylvania
- Local Institution - 0001 — Austin, Texas
- InSite Clinical Research — DeSoto, Texas
📞 Contact the Study Coordinator
Phone: (855) 907-3286
Email: Clinical.Trials@bms.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia
- Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
- Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
- Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
- Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
- Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
- Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia
Explore by condition: All Schizophrenia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.